Navigation Links
Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
Date:5/5/2011

PD) is a preventable and treatable lung disease that is the fourth leading cause of death in the United States. Each year 12 million Americans are diagnosed with COPD and an additional 12 million Americans may have COPD but remain undiagnosed. Research shows that many do not get optimal treatment.

Bronchodilator medications are central to symptom management and are prescribed on an as-needed or regular basis to prevent or reduce symptoms. Long-acting inhaled bronchodilators have been shown to be most effective and convenient. Combining bronchodilators of different pharmacological classes, as recommended by The Global Initiative for Chronic Obstructive Lung Diseases (GOLD), has been shown to improve efficacy and may decrease the risk of side effects compared to increasing the dose of a single bronchodilator. As the course of COPD progresses, regular treatment with inhaled glucocorticosteroids may be added to bronchodilator treatment. Pearl is developing inhaled combination products designed to optimize the treatment of COPD.

About Pearl Therapeutics

Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease and asthma. Pearl is rapidly advancing a pipeline of products including PT003 (GFF MDI), an inhaled, fixed-dose combination bronchodilator product comprised of a long-acting muscarinic antagonist (LAMA) and a long-acting beta-2 agonist (LABA) delivered via a metered dose inhaler (HFA MDI); and PT010 (GMFF MDI), a triple-combination product that combines the LAMA and LABA components of PT003 with an inhaled corticosteroid (ICS) for twice-daily administration from an HFA MDI for the treatment of severe COPD. Both PT003 and PT010 are developed with Pearl's proprietary porous particle cosuspension technology, which allows the formulation
'/>"/>

SOURCE Pearl Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
2. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014  Come fall, many children, teenagers, and ... they want to be for Halloween. And, a number ... decorative contact lenses bought without a prescription. ... people purchase and wear contact lenses without a prescription. ... ® consumer survey, 17 percent of Americans have ...
(Date:9/30/2014)... Sept. 30, 2014 Established and new ... distributors to help penetrate the growing Eastern European ... for a sales team and regional/local offices, reducing ... This is a crucial advantage as medical technology ... environment. New analysis from Frost & ...
(Date:9/30/2014)... -- China,s regulatory ... The country,s new leaders have recognized that the regulations ... far from perfect along with rapid population growth and ... council issued the latest "Regulations for the Supervision and ... it has come into force as June 1, 2014. ...
Breaking Medicine Technology:The Spooky Truth: What You Need To Know About Contact Lens Hygiene 2The Spooky Truth: What You Need To Know About Contact Lens Hygiene 3Global Medical Manufacturers Turn to Distributors to Tap the Eastern European Market 2Global Medical Manufacturers Turn to Distributors to Tap the Eastern European Market 3Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 5
... announced today that CH live ... Measures (i.e. eMeasures).  CredenceHealth is the first real-time Clinical ... " CCHIT is pleased to be testing ... to offer these products to providers who wish to ...
... STEWARTVILLE, Minn., Jan. 12, 2011 Rochester Medical Corporation ... reached an agreement with Fornix N.V. to purchase from ... supplies distribution company located in Beuningen, The Netherlands.  Laprolan ... the Dutch market and had unaudited revenues of approximately ...
Cached Medicine Technology:CredenceHealth's CHlive Meaningful Use Certified (ONC-ATCB 2011/2012 Certification) 2CredenceHealth's CHlive Meaningful Use Certified (ONC-ATCB 2011/2012 Certification) 3Rochester Medical Corporation Announces Agreement to Acquire Laprolan B.V. 2Rochester Medical Corporation Announces Agreement to Acquire Laprolan B.V. 3
(Date:9/30/2014)... HealthDay Reporter MONDAY, Sept. ... medical implants -- artificial valves, hip replacements, surgical mesh and ... before or after their approval by the U.S. Food and ... conducted by prominent nonprofit groups and published online Sept. 29 ... for inadequate medical device testing on lax oversight by the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Houstonians seeking ... a place to visit on the Internet. Paul ... Houston’s most respected cosmetic surgeons, has launched a new ... the benefits of Botox Cosmetic services. The ... , According to the new website, Botox Cosmetic ...
(Date:9/30/2014)... September 30, 2014 Neuromuscular and ... throughout the United States and worldwide. It is ... are diagnosed each year, adding to the more ... disease. Approximately 400,000 people in the US are ... Add to these statistics the 2.4 percent of ...
(Date:9/30/2014)... Los Angeles, CA (PRWEB) September 30, 2014 ... Farnoosh is now offering gum depigmentation treatments for dark ... but they can make people feel extremely self-conscious about ... treat discolored or dark gums. “I am one of ... lightening , and I have treated celebrities, business leaders, ...
(Date:9/30/2014)... Herceptin is the best drug treatment for a type ... standard of care for that type of tumor, according ... HER2-positive breast cancers tend to be more aggressive than ... Clinic. For the study, more than 8,300 patients ... (lapatinib) in addition to standard chemotherapy. After 4.5 ...
Breaking Medicine News(10 mins):Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 3Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 4Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 3Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 3Health News:Gummy Smile Dentist, Dr. Alex Farnoosh, is Now Offering Gum Depigmentation for Dark Gums 2
... ... announced that nine distinguished scientists have joined its Environmental Task Force to explore possible ... IDA also announced the members of the Task Force’s Steering Committee as well as ... ...
... ... for military veterans harmed by Agent Orange. , ... Parkersburg, WV (PRWEB) April 24, 2010 -- According to attorney Jan ... and ischemic heart disease should have an easier time obtaining disability benefits under a recently ...
... for American adults have stabilized while the rate of childhood ... the journal Medical Decision Making , published by SAGE. ... from 2000-2004 and validated against 2005-2006 data, the study looked ... in the United States. The research explored statistics for many ...
... yielded best results when put in those younger ... News) -- Inserting cochlear implants early significantly improves ... who have severe hearing loss, a new study ... three years in 188 children who underwent cochlear ...
... to live together happily, experts say , FRIDAY, April 23 ... to cats, enduring regular bouts of congestion, sneezing, and watery ... as an office manager for a feline veterinary hospital in ... "They showed up and never left so I took them ...
... ... Research Council , low reimbursements from public health insurance programs, such as Medicare and Medicaid, ... forcing auto insurers to more closely scrutinize and negotiate hospital bills prior to payment. ... Malvern, PA (Vocus) April ...
Cached Medicine News:Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 2Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 3Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 4Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 5Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 6Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 7Health News:New Disability Benefits Could Soon Be Available to Vietnam Vets 2Health News:New Disability Benefits Could Soon Be Available to Vietnam Vets 3Health News:Early Surgery Best for Children With Hearing Loss 2Health News:Cat Allergy Doesn't Have to Mean Giving Up Kitty 2Health News:Cat Allergy Doesn't Have to Mean Giving Up Kitty 3Health News:Hospital Cost Shifting Adds to Auto Injury Claim Costs 2Health News:Hospital Cost Shifting Adds to Auto Injury Claim Costs 3Health News:Hospital Cost Shifting Adds to Auto Injury Claim Costs 4
Ergonomic design and intuitive operations. Unique DOX digital SpO2 technology improves performance, even under the most challenging clinical conditions....
The OX-2 is configured asstandalone or handheld unit, designed for hospital, transport and home use....
... Radical can operate in two additional ... be removed, creating a fully featured handheld ... also be used to upgrade existing equipment ... additinal hardware or software upgrades to improve ...
... technology is the first and ... patented digital sensor all ... sensor. Dolphin ONE™ sensors both ... in the sensor, resulting in ...
Medicine Products: